According to research data from the US Centers for Disease Control and Prevention (CDC), while the advancements in modern medicine over the past century have extended the maximum lifespan of humans, the proportion of healthy lifespan (Healthspan) has not increased accordingly. Instead, unhealthy modern lifestyles have led to an increasing period of human suffering from illnesses, contributing to population aging and a shortage of healthy labor, posing a serious challenge to future societal development.
How to extend a healthy, productive human lifespan? The organ age management brand LAIFE, based in Boston, is actively providing answers.
Originating from an innate exploration of life health by a group of Harvard graduates in the renowned global life science hub of Boston, LAIFE has formed a research team driven by artificial intelligence and cloud-based supercomputing. This team successfully combines AI technology with biology, developing the technology platform of the “Organ Aging Clock” and establishing the LAIFE brand.
Leveraging artificial intelligence tools for exploratory research, LAIFE introduces a novel methodology to organ age measurements and nutritional supplements, significantly accelerating the development of safe, effective, and innovative solutions, therefore shredding some light into a new era of anti-aging.
Parent Company Regenerative Bio Receives Significant Investment
With a vision of “health equality – graceful aging for everyone”, the LAIFE brand is supported by a robust research team and practical intervention products, while backed up by top-tier venture capitals. In 2022, LAIFE’s parent company, Regenerative Bio, announced the completion of Angel and Angel Plus funding rounds of nearly 10 million dollars. The angel round was led by IMO Ventures, with K2VC, Uphonest Capital, and Taihill Venture as co-investors. The angel+ round was led by 5Y Capital, with Yael Capital as a co-investor. These funds will support platform construction, AI models and algorithms optimization, and LAIFE promotion.
Exceptional Research Team
LAIFE’s Science Advisory Board is led by Dr. George Church, whose innovations have contributed to nearly all “next generation” DNA sequencing methods and companies, plus his lab’s work on chip-DNA-synthesis, gene editing, and stem cell engineering resulted in founding additional application-based companies spanning fields of medical diagnostics & synthetic biology/therapeutics. He has also pioneered new privacy, biosafety, ELSI, and environmental & biosecurity policies. He was director of an IARPA BRAIN Project and 3 NIH Centers for Excellence in Genomic Science. His honors include election to the National Academy of Science & National Academy of Engineering & Franklin Bower Laureate for Achievement in Science.
Scientific advisors of Regenerative Bio also include Dr. Vadim Gladyshev, Fellow of the National Academy of Sciences and a trailblazer in aging clock research, Dr. Tian Xu, previously C.N.H. LONG Professor of Genetics and the Special Advisor to President of Yale University, and currently Chair Professor of Genetics and Vice President at Westlake University, as well as a world-renowned expert on the mechanism of growth control and new genetic and biotech methods.
In addition to these distinguished advisors, LAIFE’s team includes key members from the world’s top medical institutions, laboratories, and hospitals, recognized for their outstanding research achievements in biomedicine, aging, and related fields.
Market-Leading Intervention Products
LAIFE has revolutionized the anti-aging market by ingeniously blending biology and AI, resulting in the introduction of a suite of cutting-edge organ age intervention products. This diverse portfolio includes the ANTI-AGING Zero, a comprehensive anti-aging solution targeting core organs, the LAIFE OVAREVIVE™ ovarian anti-aging capsule, tailored specifically for women, the LAIFE MALE ANTI-AGING capsule, designed to meet the unique needs of men, the LAIFE LIVER REJUVE capsule, specializing in liver anti-aging, and the LAIFE SHIELD immune shield tablet. These meticulously crafted products, meticulously validated by the market, have garnered consistent and positive feedback from satisfied consumers.
LAIFE’s commitment to innovation extends beyond product development. The company leverages its proprietary AI technology platform, RevOrgan™, to meticulously select components based on organ aging models. This approach involves the intricate design of component formulations, optimization of crystal structures, and the implementation of multiple efficacy verifications. The result is a targeted anti-aging solution for human organs, providing consumers with safe, efficient, and long-term-use nutritional supplements.
Paving the Way for Future Developments
In the relentless pursuit of enhancing health and extending the human lifespan, LAIFE recognizes the enduring concerns of humanity. The company views the field of aging research as not only a promising avenue for exploration but also a dynamic business direction with vast potential.
Underlining its commitment to achieving a superior LIFE through the power of AI, LAIFE plans to fully exploit the advantages of artificial intelligence. The company is poised to introduce more precise organ aging clock detection services, comprehensive intervention products, and a sophisticated organ age tracking management service. This unwavering commitment underscores LAIFE’s dedication to making continuous and groundbreaking contributions to the ever-evolving field of human anti-aging.